Evaluation of MicroRNA-210(miR-210) as a Diagnostic and Prognostic Biomarker in Pre-eclampsia Pregnancies

Correlation of Fibroblast Growth Factor 21 (FGF-21) with Fetal and Maternal Complications in Patients with Gestational Diabetes Mellitus

Relationship of Serum MicroRNA-26a and GSK-3β Levels with Metabolic Syndrome in Women with Obesity

Evaluation of miR-181a in Diabetes Mellitus Type-2 and its relation to Diabetic Nephropathy

Predictive value of microRNA-210 in preeclampsia

Possible Correlation between Severity of Retinopathy and Blood Levels of miRNAs (-146, -21 and 34a) in Type 2 Diabetic Patients.

Role of MicroRNA-155 in Pathogenesis and Prognosis of Preeclampsia pregnancies

EVALUATION OF MATERNAL SERUM PENTRAXIN 3 AS A NOVEL DIAGNOSTIC BIOMARKER IN GESTATIONAL DIABETES MELLITUS

Epigenetic Effect of MicroRNA in Coronary Heart Disease With and Without Diabetes

Study of MicroRNA192 as an Early Marker of Nephropathy in Type 2 Diabetic Patients